(ACTH) and serum cortisol levels (6 pg/ml and 41.4 |ug/dl together with plasma glucose 51 mg/dl on the next morning of admission, respectively) seemed to be compatible with isolated ACTH deficiency and replacement of hydrocortisone (10 mg/day) was initiated. However, further endocrinological examinations revealed autonomic cortisol secretion and finally, this patient was diagnosed as preclinical Cushing's syndrome in spite of successful hydrocortisone replacement. During the follow-up period, his general condition became unstable after the dose of hydrocortisone decreased to 5 mg/day due to the diagnosis of preclinical Cushing' s syndrome. Thereafter, he manifested dehydration because of severe diarrhea, which was improved by oral administration of hydrocortisone (10 mg/day). Then, we examined the possible expression of IGF-II to rule out NICTH using a serum sample obtained during cessation of hydrocortisone. Western immunoblot analysis (2) of the patient's serum showed the big form of IGF-II in addition to authentic IGF-II (7.5 kDa) (Fig. 1, lane 3 (Fig. 1) , which could be modulated by hydrocortisone replacement (3, 4), strongly indicates that the present case may also be complicated by IGF-II-producing tumor. So, we hypothesize that NICTH may be related to severe hypoglycemia in the present case, although Lloyd et al (5) 
